XWPharma Names Michael M. Morrissey, PhD to Board of Directors
Appointment Adds Senior Biopharma Operational Expertise to Board Oversight as Company Advances its Pipeline of Novel CNS Therapeutics in Research and Clinical Development Appointment Adds Senior Biopharma Operational Expertise to Board Oversight as Company Advances its Pipeline of Novel CNS Therapeutics in Research and Clinical Development
Read the rest here:
XWPharma Names Michael M. Morrissey, PhD to Board of Directors